Company news
OpSens Inc news in 2018
OpSens Inc's news releases, calls and decks from 2018, newest first.
UPDATE - Opsens reports Q4 and FY2018 results
November 28, 2018
Opsens receives Health Canada approval for dPR intended for the diagnosis of coronary stenosis with the heart at rest
November 27, 2018
Opsens - First use of dPR for the diagnosis of coronary stenosis with the heart at rest
November 8, 2018
Opsens - 50,000 patients diagnosed with the OptoWire
November 1, 2018
Opsens to Host Investor Webinar on Thursday, October 4 to Provide Update on Recent Developments
October 3, 2018
Opsens - New product for the diagnosis of coronary stenosis with the heart at rest
September 20, 2018
Opsens Reports Q3 2018 Results - Quarterly Revenues Eclipse $6.4 M
July 12, 2018
Opsens applauds Japanese government new regulation supporting diagnosis, such as FFR, before treatment of coronary stenosis
April 24, 2018
Opsens reports Q2 2018 results - Consolidated product sales up 44%
April 12, 2018
Opsens' technology granted FDA approval in Abiomed's Impella Cardiac PumpĀ®
April 3, 2018
Opsens Reports Results of Shareholders Vote
January 31, 2018
Opsens Announces Election Results for the Board of Directors and the Retirement of Claude Belleville
January 23, 2018
Opsens Reports Q1 2018 Results - Record Quarterly Revenues With Growth in all Geographic Regions
January 15, 2018